All In MedTech

Device Trial Radar · NCT01347931

In-home Evaluation of a Noninvasive Open Ventilation System in Patients With Severe Respiratory Insufficiency

In-home Evaluation of the Breathe Technologies Noninvasive Open Ventilation (NIOV™) System in Patients With Severe Respiratory Insufficiency

Last checked: Nov 20, 2026Latest source record: Oct 11, 2016 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registry

Status

Completed

Enrollment

30

Actual

Start

May 2011

Primary completion

Mar 2012

Study completion Mar 2012

Sponsor

Lead sponsor
Breathe Technologies, Inc.Not on our public-company list
Sponsor type
Industry
First posted
May 5, 2011

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Non randomized
Model
Crossover
Masking
None
Primary purpose
Treatment
Who can join
All sexes, from 21 years, up to 80 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The Breathe NIOV™ System will reduce the work of breathing in subjects with chronic respiratory insufficiency who require long-term oxygen therapy (LTOT). The Breathe system will accomplish this by providing oxygen under pressure and augmenting the subject's spontaneous tidal volumes. The combination of efficient oxygen delivery, assisted ventilation, and a comfortable low-profile device, will result in a mean improvement in perceived well-being and ability to perform ADLs, as measured by patient-reported outcome (PRO) instruments.

Conditions

  • Pulmonary Disease, Chronic Obstructive
  • Airflow Obstruction, Chronic
  • Chronic Obstructive Airway Disease
  • Chronic Obstructive Lung Disease

Interventions

  • NIOV SystemDevice

    Each subject's standard oxygen therapy will be used as the control treatment and compared to the test ventilator (NIOV) system during selected activities of daily living.

  • Standard Oxygen CannulaDevice

    Supplemental oxygen via a standard oxygen cannula connected to a portable oxygen cylinder

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Activity Endurance TimeTime frame: Measured during single day study visit

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Allegheny General Hospital

    Pittsburgh, Pennsylvania

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.